NANOFORM FINLAND OYJ
Research NANOFORM FINLAND OYJ (4YL) on Bullrun: market cap EUR 80.27M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4YL
- ExchangeF
- CountryFinland
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 80.27M
- Financial periodQ1 2026
- RevenueEUR 1.27M
- Net income-EUR 3.43M
- Free cash flow-EUR 3.76M
- Gross margin94.2%
Valuation Snapshot
latest market cap is EUR 80.27M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 3.55M | -EUR 17.90M | -EUR 18.80M | 85.8% | -0.21 | EUR 24.00M | EUR 6.21M | EUR 42.78M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 80.27M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About NANOFORM FINLAND OYJ
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and dosage forms of Nanoparticles.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is NANOFORM FINLAND OYJ's market cap?
NANOFORM FINLAND OYJ's market capitalization is EUR 80.27M.
What does NANOFORM FINLAND OYJ do?
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and dosage forms of Nanoparticles.